Episode Details

Back to Episodes
Lower Drug Prices through the Inflation Reduction Act at risk in 2025? w/ Alex Lawson, Social Security Works

Lower Drug Prices through the Inflation Reduction Act at risk in 2025? w/ Alex Lawson, Social Security Works

Season 3 Episode 1 Published 1 year, 6 months ago
Description

Could the Inflation Reduction Act and Medicare drug price negotiation really be at risk in 2025? Alex Lawson from Social Security Works talks about the future of the Inflation Reduction Act under President Donald Trump including Medicare drug price negotiations and out of pocket prescription drug and insulin co-pay caps, Project 2025, and what may happen next year that could raise the cost of medications in America.

Plus experts including show host, stage 4 cancer survivor and health care advocate Laura Packard from Health Care Voices, Diane Archer from JustCare and Louise Norris from HealthInsurance.org answer your health care and health insurance questions.

This episode includes more about open enrollment for Medicare. What’s going on, how long does it last, who needs to take action and what do you need to do? And more about open enrollment for the Affordable Care Act. When is it, what do you need to do, who is eligible?

New episodes of Care Talk every Tuesday, subscribe wherever you get your podcasts. Call or text your health insurance and health care questions in to (202) 838-6837 to get answers in future shows!

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us